Utah Admin. Code R156-67-102 - Definitions

Terms used in this rule are defined in Title 58, Chapter 1, Division of Professional Licensing Act, and Title 58, Chapter 67, Utah Medical Practice Act. In addition:

(1) "ACCME" means the Accreditation Council for Continuing Medical Education.

(2) "Alternate medical practices" as used in Section R156-67-603, means treatment or therapy that is determined in an adjudicative proceeding under Title 63G, Chapter 4, Administrative Procedures Act, to be:

(a) not generally recognized as standard in the practice of medicine;

(b) not shown by current generally accepted medical evidence to present a greater risk to the health, safety, or welfare of the patient than does prevailing treatment considered to be the standard in the profession of medicine; and

(c) supported by a body of current generally accepted written documentation demonstrating the treatment or therapy has reasonable potential to be of benefit to the patient to whom the therapy or treatment is to be given.

(3) "AMA" means the American Medical Association.

(4) "Collaborative practice arrangement contract" means a written, signed contract between a collaborating physician licensed and in good standing under Section 58-67-302, and an associate physician holding a restricted license in accordance with Section 58-67-302.8, that:

(a) includes the terms and conditions required by Section 58-67-807 and Section R156-67-807; and

(b) is approved by the Division in accordance with Section 58-67-807 and Section R156-67-807.

(5) "FLEX" means the Federation of State Medical Boards Licensing Examination.

(6) "FMGEMS" means the Foreign Medical Graduate Examination in Medical Science.

(7) "FSMB" means the Federation of State Medical Boards.

(8) "Homeopathic medicine" means a system of medicine employing and limited to substances prepared and prescribed in accordance with the principles of homeopathic pharmacology as described in the Homeopathic Pharmacopoeia of the United States, its compendia, addenda, and supplements, as officially recognized by:

(a) the Federal Food, Drug and Cosmetic Act, 21 U.S.C. Sec. 301 et seq.;

(b) Utah's food and drug laws; and

(c) Title 58, Chapter 37, Utah Controlled Substances Act.

(9) "LMCC" means the Licentiate of the Medical Council of Canada.

(10) "Medication or substance, including a neurotoxin or a filler, for cosmetic purposes" as used in the definition of cosmetic medical procedure in Subsection 58-67-102(11)(a)(ii) means a medication or substance that is approved by the U.S. Food and Drug Administration (FDA) for use in humans for cosmetic purposes and is used according to FDA guidelines.

(11) "NBME" means the National Board of Medical Examiners.

(12) "Unprofessional conduct" under Subsection 58-1-203(1)(e) is further defined in Section R156-67-502.

(13) "USMLE" means the United States Medical Licensing Examination.

Notes

Utah Admin. Code R156-67-102

Amended by Utah State Bulletin Number 2018-21, effective 10/9/2018 Amended by Utah State Bulletin Number 2023-03, effective 1/12/2023 Amended by Utah State Bulletin Number 2025-01, effective 12/24/2024